AG

Artal Group Portfolio holdings

AUM $930M
This Quarter Return
+29.93%
1 Year Return
-3.57%
3 Year Return
+157.23%
5 Year Return
+160.22%
10 Year Return
+1,359.85%
AUM
$2.38B
AUM Growth
+$2.38B
Cap. Flow
-$2.22B
Cap. Flow %
-93.38%
Top 10 Hldgs %
100%
Holding
109
New
–
Increased
–
Reduced
2
Closed
107

Top Buys

No buys this quarter

Top Sells

1
CAVA icon
CAVA Group
CAVA
$743M
2
SRRK icon
Scholar Rock
SRRK
$93.8M
3
KYMR icon
Kymera Therapeutics
KYMR
$89.7M
4
MORF
Morphic Holding, Inc. Common Stock
MORF
$86.1M
5
ARWR icon
Arrowhead Research
ARWR
$82.9M

Sector Composition

1 Consumer Discretionary 91.02%
2 Healthcare 8.98%
3 Communication Services 0%
4 Real Estate 0%
5 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
RAPP
101
Rapport Therapeutics
RAPP
$549M
– –
-350,000
Closed -$8.14M
ONC
102
BeOne Medicines Ltd. American Depositary Shares
ONC
$37B
– –
-303,369
Closed -$43.3M
KLRS
103
Kalaris Therapeutics, Inc. Common Stock
KLRS
$85.5M
– –
-6,597,167
Closed -$4.77M
ACHL
104
DELISTED
Achilles Therapeutics plc American Depositary Shares
ACHL
– –
-755,375
Closed -$616K
SYRS
105
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
– –
-2,505,013
Closed -$12.9M
OMGA
106
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
– –
-1,323,530
Closed -$2.74M
PFTAW
107
DELISTED
Perception Capital Corp. III Warrant
PFTAW
– –
-126,666
Closed -$3.55K
GRTS
108
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
– –
-3,030,952
Closed -$1.87M
MORF
109
DELISTED
Morphic Holding, Inc. Common Stock
MORF
– –
-2,525,998
Closed -$86.1M
1 2 3 4
5